This study is open to adults with extensive-stage small cell lung cancer. The purpose of this study is to find out how well people with this type of cancer tol…

Extensive-stage Small Cell Lung CarcinomaAdvanced Small Cell Lung Cancer

~Estimated

~$10 – $7,500

Boehringer IngelheimNCT07843940

Phase 1

A Feasibility Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Background: A type of drug called monoclonal antibody immune checkpoint inhibitors are often used in cancer treatment. These drugs help the body s immune syst…

Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more

~Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT06066138